Icthic Magazine

Home › Archive

Inpatient thromboprophylaxis in cancer patients: what is the evidence? A talk report from the 10th ICTHIC

During the 10th ICTHIC, Prof. Jeffrey Zwicker (Harvard Medical School, MA, USA) gave an overview of the evidence of the...

Cancer-associated thrombosis (CAT) is the most frequent cause of death in patients with cancer after cancer itself . In...

Lung cancer is associated with a very high risk of developing venous thromboembolism (VTE). In a large...

During the 10th ICTHIC, Dr. Avi Leader (hematologist at Rabin Medical Center in Petah Tikva, Israel) talked about...

Blood clot generation in people with cancer follows a process distinct from the non-cancer population. Cancer tissue is...

D-dimer is a marker of coagulation activation and thrombotic activity. The analysis of D-dimer levels is used to...

Patients with cancer are at high risk of venous thromboembolism (VTE). Fortunately, patient survival, diagnostic tools...

During the 10th ICTHIC, Prof. Marcello di Nisio (University of Chieti, Italy) and Prof. Marc Carrier (Ottawa Hospital...

Atrial fibrillation (AF) is common in patients with cancer, and up to one in every four persons with AF has comorbid...

The management of cancer-associated venous thrombosis (CAT) is particularly challenging because of a high risk of major...